The Health Minister said the decision followed the acceptance of the committee set up by the Ministry of Health to explore the public policy of the Valued Added Tax (VAT) Exemptions on all medicines listed in the Essential Medicines List 2017, in addition to pharmaceutical imputes, to reduce the burden of reimbursements on the NHIS.
“I must say that some of the prices have been dropped more than 80 per cent,” he said.
Mr Agyeman-Manu, who made the announcement at the launch of the National Medicines Policy and Five-Year Implementation Plan for Ghana in Accra, expressed his gratitude to the Pharmaceutical Manufacturers Association of Ghana (PMAG), the Chamber of Pharmacy, and all the other stakeholders for their support and hard work.
“We are here because you believe in the process and that our road to Universal Health Coverage is to sustain our national health insurance scheme so that no one is left behind,” he said.
The Health Minister said the prices of pharmaceuticals remained a big challenge to the country, and the government, in fulfilment to its manifesto promise, therefore removed the Valued Added Tax (VAT) on all medicines listed in the Essential Medicines List 2017 in addition to pharmaceutical imputes.
Mr Agyeman-Manu said the VAT exemptions came into force on November 3, 2017, and this action, the government believed, should lead to reduction in prices since VAT formed about 40 per cent of the total taxes on pharmaceuticals.
Dr Owen Laws Kaluwa, the WHO Country Representative, called for strengthened stakeholder partnership in the implementation process of the National Medicines Policy, and not to allow the document to gather dust on the selves as other had suffered.
He pledged the WHO’s sustained commitment to support the implementation of the policy in order to ensure access to essential medicines and further help Ghana to achieve the Sustainable Development Goals through Universal Health Coverage.